JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB89780

Anti-MAG/GMA antibody [3C7] - BSA and Azide free

5

(19 Reviews)

|

(73 Publications)

Mouse Monoclonal MAG/GMA antibody. Carrier free. Suitable for ICC, Flow Cyt, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 73 publications. Immunogen corresponding to Recombinant Fragment Protein within Human MAG aa 100-250.

View Alternative Names

GMA, MAG, Myelin-associated glycoprotein, Siglec-4a

4 Images
Immunocytochemistry - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)
  • ICC

Lab

Immunocytochemistry - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)

ab89780 stained SKNSH cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab89780 at 10μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- mouse (ab96879) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

This image was generated using the ascites version of the product.

Flow Cytometry - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)

Overlay histogram showing SH-SY5Y cells stained with ab89780 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab89780, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in SH-SY5Y cells fixed with 80% methanol (5 min) used under the same conditions.
Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.

This image was generated using the ascites version of the product.

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)
  • WB

Unknown

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (ab89780) at 5 µg/mL

All lanes:

Jurkat cell lysate at 50 µg

Predicted band size: 69 kDa

Observed band size: 53 kDa

false

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)
  • WB

Unknown

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (AB89780)

Western blot against tagged recombinant protein immunogen. Predicted band size of immunogen is 36 kDa.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MAG/GMA antibody [3C7] - BSA and Azide free (ab89780) at 5 µg/mL

All lanes:

Partial tagged recombinant Human MAG/GMA protein at 0.2 µg

Predicted band size: 69 kDa

Observed band size: 36 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

3C7

Isotype

IgG1

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

ICC, Flow Cyt, WB

applications

Immunogen

Recombinant Fragment Protein within Human MAG aa 100-250. The exact immunogen used to generate this antibody is proprietary information.

P20916

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>Isoform a, 69 kDa; Isoform b, 63 kDa.</p>" }, "Orangutan": { "ICC-species-checked": "predicted", "ICC-species-dilution-info": "", "ICC-species-notes": "", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant fragment - Human": { "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>Isoform a, 69 kDa; Isoform b, 63 kDa.</p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 4th April 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MAG (Myelin-Associated Glycoprotein) sometimes referred to as 'MAG protein' 'MAG RAT' or 'MAG/GMA' weighs approximately 100 kDa. This protein is prominently expressed in the central and peripheral nervous systems. MAG localizes to the periaxonal region of myelinated axons making it essential for proper neuronal function. It plays an important role in maintaining the stability and structure of myelin sheaths which are important for the efficient transmission of nerve impulses.
Biological function summary

This protein acts as an adhesion molecule that contributes to the myelination process. It exists as part of a molecular complex that interacts with other oligodendrocyte and Schwann cell proteins. This interaction is important for nerve regeneration and the expansion of the myelin sheath during development and repair. MAG also assists in signaling between axons and glial cells improving cellular communication and myelin integrity.

Pathways

MAG significantly impacts pathways such as the Nogo receptor which is associated with inhibiting axonal growth and regeneration. MAG interacts with the NOGO protein and other members of the Nogo receptor signaling pathway where it functions to regulate neuronal growth and regeneration. Furthermore MAG's interplay with NOGO receptor components contributes to limiting excessive sprouting of axons balancing growth and stability of the nervous system.

MAG is notably linked to neuropathies and multiple sclerosis. In neuropathies abnormal MAG expression can disrupt nerve conduction and lead to demyelinating conditions. Multiple sclerosis sees extensive involvement of MAG where its malfunction or reduced expression associates with the failure of remyelination processes. Additionally MAG's connection with proteins such as NOGO and other myelin-associated inhibitors implicates its role in the pathology of these disorders offering potential targets for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (By similarity). Not required for initial myelination, but seems to play a role in the maintenance of normal axon myelination. Protects motoneurons against apoptosis, also after injury; protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2. Required to prevent degeneration of myelinated axons in adults; this probably depends on binding to gangliosides on the axon cell membrane (By similarity). Negative regulator of neurite outgrowth; in dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides. In cerebellar granule cells the inhibition is mediated primarily via binding to neuronal gangliosides. In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides. Inhibits axon longitudinal growth (By similarity). Inhibits axon outgrowth by binding to RTN4R (By similarity). Preferentially binds to alpha-2,3-linked sialic acid. Binds ganglioside Gt1b (By similarity).
See full target information MAG

Publications (73)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:4216 PubMed39905182

2025

Siponimod supports remyelination in the non-supportive environment.

Applications

Unspecified application

Species

Unspecified reactive species

Johann Krüger,Newshan Behrangi,David Schliep,Leo Heinig,Elise Vankriekelsvenne,Nicole Wigger,Markus Kipp

Molecular psychiatry 29:3381-3394 PubMed38740879

2024

Adenosine mediates the amelioration of social novelty deficits during rhythmic light treatment of 16p11.2 deletion female mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Ju,Xuanyi Li,Yifan Pan,Jun Du,Xinyi Yang,Siqi Men,Bo Liu,Zhenyu Zhang,Haolin Zhong,Jinyuan Mai,Yizheng Wang,Sheng-Tao Hou

CNS neuroscience & therapeutics 30:e14742 PubMed38715283

2024

Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhao Xu,Limoran Tang,Chao Zhou,Liang Sun,Yujie Hu,Zhi Zhang,Shengnan Xia,Xinyu Bao,Haiyan Yang,Yun Xu

Frontiers in molecular neuroscience 16:1323449 PubMed38163061

2024

Severe central nervous system demyelination in Sanfilippo disease.

Applications

Unspecified application

Species

Unspecified reactive species

Mahsa Taherzadeh,Erjun Zhang,Irene Londono,Benjamin De Leener,Sophie Wang,Jonathan D Cooper,Timothy E Kennedy,Carlos R Morales,Zesheng Chen,Gregory A Lodygensky,Alexey V Pshezhetsky

Genome medicine 15:109 PubMed38082331

2023

Acute ischemia induces spatially and transcriptionally distinct microglial subclusters.

Applications

Unspecified application

Species

Unspecified reactive species

Huiya Li,Pinyi Liu,Bing Zhang,Zengqiang Yuan,Mengdi Guo,Xinxin Zou,Yi Qian,Shiji Deng,Liwen Zhu,Xiang Cao,Tao Tao,Shengnan Xia,Xinyu Bao,Yun Xu

Nature communications 14:7090 PubMed37925436

2023

Systemic and intrinsic functions of ATRX in glial cell fate and CNS myelination in male mice.

Applications

Unspecified application

Species

Unspecified reactive species

Megan E Rowland,Yan Jiang,Sarfraz Shafiq,Alireza Ghahramani,Miguel A Pena-Ortiz,Vanessa Dumeaux,Nathalie G Bérubé

Glia 72:375-395 PubMed37909242

2023

Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.

Applications

Unspecified application

Species

Unspecified reactive species

Katharine E Askew,Joshua Beverley,Emma Sigfridsson,Stefan Szymkowiak,Katherine Emelianova,Owen Dando,Giles E Hardingham,Jessica Duncombe,Edel Hennessy,Juraj Koudelka,Neshika Samarasekera,Rustam Al-Shahi Salman,Colin Smith,Adriana A S Tavares,Diego Gomez-Nicola,Raj N Kalaria,Barry W McColl,Karen Horsburgh

JCI insight 8: PubMed37097758

2023

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Soumya S Yandamuri,Beata Filipek,Abeer H Obaid,Nikhil Lele,Joshua M Thurman,Naila Makhani,Richard J Nowak,Yong Guo,Claudia F Lucchinetti,Eoin P Flanagan,Erin E Longbrake,Kevin C O'Connor

Journal of neuropathology and experimental neurology 82:457-466 PubMed37071794

2023

Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas G Beach,Lucia I Sue,Sarah Scott,Anthony J Intorcia,Jessica E Walker,Richard A Arce,Michael J Glass,Claryssa I Borja,Madison P Cline,Spencer J Hemmingsen,Sanaria Qiji,Analisa Stewart,Kayleigh N Martinez,Addison Krupp,Rylee McHattie,Monica Mariner,Ileana Lorenzini,Angela Kuramoto,Kathy E Long,Cécilia Tremblay,Richard J Caselli,Bryan K Woodruff,Steven Z Rapscak,Christine M Belden,Danielle Goldfarb,Parichita Choudhury,Erika D Driver-Dunckley,Shyamal H Mehta,Marwan N Sabbagh,Holly A Shill,Alireza Atri,Charles H Adler,Geidy E Serrano

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 185:106441 PubMed37004962

2023

Phosphodiesterase (PDE) 4 inhibition boosts Schwann cell myelination in a 3D regeneration model.

Applications

Unspecified application

Species

Unspecified reactive species

Melissa Schepers,Afonso Malheiro,Adrián Seijas Gamardo,Niels Hellings,Jos Prickaerts,Lorenzo Moroni,Tim Vanmierlo,Paul Wieringa
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com